Review
K-Cl cotransporters, cell volume homeostasis, and neurological disease

https://doi.org/10.1016/j.molmed.2015.05.008Get rights and content

Highlights

  • KCCs have roles in the nervous system beyond modulating GABAergic signaling.

  • KCCs regulate nervous system cell volume, and are mutated in neurological disease.

  • WNK-SPAK kinases modulate volume-sensitive KCC activity.

  • Antagonizing WNK-SPAK-mediated KCC phosphorylation may hold therapeutic promise.

K+-Cl cotransporters (KCCs) were originally characterized as regulators of red blood cell (RBC) volume. Since then, four distinct KCCs have been cloned, and their importance for volume regulation has been demonstrated in other cell types. Genetic models of certain KCCs, such as KCC3, and their inhibitory WNK-STE20/SPS1-related proline/alanine-rich kinase (SPAK) serine-threonine kinases, have demonstrated the evolutionary necessity of these molecules for nervous system cell volume regulation, structure, and function, and their involvement in neurological disease. The recent characterization of a swelling-activated dephosphorylation mechanism that potently stimulates the KCCs has pinpointed a potentially druggable switch of KCC activity. An improved understanding of WNK/SPAK-mediated KCC cell volume regulation in the nervous system might reveal novel avenues for the treatment of multiple neurological diseases.

Section snippets

Cation-Cl cotransporters in the brain: beyond NKCC1 and KCC2

Cation-chloride cotransporters (CCCs) are among the most medically relevant ion transporters in the human genome. Multiple members of this family [1], and their upstream regulators [i.e., the Kelch-like family member 3 (KLHL3)/Cullin 3 (CUL3)-WNK-SPAK/Oxidative stress response 1 (OSR1) kinase signaling pathway [2]], are mutated in human Mendelian disorders featuring brain or renal phenotypes resulting from impaired ion homeostasis. CCCs are also targets of several commonly used drugs utilized

Cell volume regulation in the nervous system

Defense against significant changes in cell volume is required for cell function and survival [33]. Cell volume perturbations can result from changes in intracellular osmolarity (isosmotic volume stress) or extracellular osmotic pressure (anisosmotic volume stress). Isosmotic cell swelling, as occurs in cellular energetic failures such as ischemic stroke, results in increases in the intracellular concentration of Na+ ([Na+]i) and [Cl]i. Anisosmotic cell swelling, as seen in acute hyponatremia

Swelling-sensitive KCCs in the nervous system

The structure, function, and regulation of the KCCs are highly conserved across evolution, consistent with their essential role in physiology [24]. Since human KCC1 was first cloned in 1996, four human genes encoding human KCCs (hKCC1–4) have been identified, which all have mouse and rat orthologs 19, 25, 44, 45, 46, 47, 48. hKCCs share a similar membrane topology, including hydrophilic N- and C-terminal intracellular domains harboring multiple phosphoresidues important for transporter

KCC3 is essential for nervous system cell volume regulation

Evidence that KCCs are important for cell volume maintenance in the nervous system has been derived from genetically modified worms and flies 47, 54, transgenic or knockout mouse models [31], and human patients with inherited disease-causing mutations 28, 31. Delpire and colleagues first disrupted the KCC3-encoding Slc12a6 gene using homologous recombination in mice [31]. Slc12a6–/– but not Slc12a6–/+ mice exhibited weakness and incoordination of rear limbs by 2 weeks of age, correlating with

KCC3 is required for normal structure and function of the human nervous system

Molecular genetics has also established the necessity of KCC3-mediated cell volume regulation in humans. Loss-of-function mutations in KCC3 have been identified as the cause of agenesis of the corpus callosum associated with peripheral neuropathy [ACCPN or hereditary motor and sensory neuropathy/absent corpus collosum (HSMN/ACC)], a severe sensorimotor neuropathy associated with mental retardation, dysmorphic features, and complete or partial agenesis of the corpus callosum [66]. ACCPN is

The Cl-sensitive WNK-SPAK kinase complex: master regulator of KCC and N[K]CC volume sensitivity

Until recently, the mechanisms regulating KCC swelling sensitivity were not defined on the molecular level. While cell swelling is a quasi-immediate phenomenon due to the water permeability of a cell membrane, there is a significant time delay in the activation of K+-Cl cotransport [20]. This delay is temperature dependent, indicating that swelling activation is an energy and/or metabolic-dependent process. In fact, based on kinetic arguments and the use of phosphatase inhibitors, early

Modulation of KCC3 swell activation mechanisms to counter pathological brain swelling

Blocking KCC3 Thr991/Thr1048 inhibitory phosphorylation is a potent mechanism of stimulating KCC activity. Could this mechanism be pharmacologically exploited to protect against isosmotic cell swelling in certain disease states, such as cerebral edema associated with ischemic stroke, epilepsy, or tumors? Interestingly, the sequence context of the KCC phosphorylation site 1 is also conserved in the amino terminus of NKCC1, suggesting a coordinated but opposite regulation of NKCCs and KCCs by a

Exploiting KCC swell activation mechanisms for neurological diseases not associated with cell swelling

Might it also be possible to exploit the biochemical mechanisms of NKCC1 and KCC2 swelling regulation for therapeutic benefit in neurological diseases not associated with cell swelling? Multiple diseases, including seizures, neuropathic pain, autism, schizophrenia, spasticity, and others, feature more depolarized values of EGABA, and hyperexcitability of GABAergic neurons and circuits, due to pathologically elevated neuronal [Cl]i resulting from increases in NKCC1 activity, or decreases in

Concluding remarks

In neuroscience, considerable attention has been rightly paid to KCC2, which mediates Cl efflux in isotonic conditions and is required for the establishment of GABAergic hyperpolarizing synaptic inhibition. However, genetic models of KCC3 and KCC4, and their upstream inhibitory WNK-SPAK kinases, have demonstrated the necessity of swelling-regulated K-Cl cotransport for nervous system development and cell volume regulation, and their involvement in neurological disease. The recent discovery and

References (108)

  • C.M. Gillen

    Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human. A new member of the cation-chloride cotransporter family

    J. Biol. Chem.

    (1996)
  • K. Hiki

    Cloning, characterization, and chromosomal location of a novel human K+-Cl cotransporter

    J. Biol. Chem.

    (1999)
  • C.M. Pellegrino

    Molecular identification and expression of erythroid K:Cl cotransporter in human and mouse erythroleukemic cells

    Blood Cells Mol. Dis.

    (1998)
  • A. Mercado

    Functional comparison of the K+-Cl cotransporters KCC1 and KCC4

    J. Biol. Chem.

    (2000)
  • Y. Jiao

    A deletion mutation in Slc12a6 is associated with neuromuscular disease in gaxp mice

    Genomics

    (2008)
  • S. Casula

    A dominant negative mutant of the KCC1 K-Cl cotransporter both N-and C-terminal cytoplasmic domains are required for K-Cl cotransport activity

    J. Biol. Chem.

    (2001)
  • C.F. Simard

    Homooligomeric and heterooligomeric associations between K+-Cl cotransporter isoforms and between K+-Cl and Na+-K+-Cl cotransporters

    J. Biol. Chem.

    (2007)
  • T. Olsson

    Cell swelling, seizures and spreading depression: an impedance study

    Neuroscience

    (2006)
  • M. Isokawa

    N-methyl-d-aspartic acid-induced and Ca-dependent neuronal swelling and its retardation by brain-derived neurotrophic factor in the epileptic hippocampus

    Neuroscience

    (2005)
  • J. Ding et al.

    Deletion of KCC3 in parvalbumin neurons leads to locomotor deficit in a conditional mouse model of peripheral neuropathy associated with agenesis of the corpus callosum

    Behav. Brain Res.

    (2014)
  • M. Shekarabi

    Cellular expression of the K+–Cl cotransporter KCC3 in the central nervous system of mouse

    Brain Res.

    (2011)
  • P.K. Lauf

    K-Cl co-transport: immunocytochemical and functional evidence for more than one KCC isoform in high K and low K sheep erythrocytes

    Comp. Biochem. Physiol. A: Mol. Integr. Physiol.

    (2001)
  • J. Rinehart

    Sites of regulated phosphorylation that control K-Cl cotransporter activity

    Cell

    (2009)
  • A. Salin-Cantegrel

    Transit defect of potassium-chloride co-transporter 3 is a major pathogenic mechanism in hereditary motor and sensory neuropathy with agenesis of the corpus callosum

    J. Biol. Chem.

    (2011)
  • K. Piechotta

    Cation chloride cotransporters interact with the stress-related kinases ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1)

    J. Biol. Chem.

    (2002)
  • K. Piechotta

    Characterization of the interaction of the stress kinase SPAK with the Na+-K+-2Cl cotransporter in the nervous system: evidence for a scaffolding role of the kinase

    J. Biol. Chem.

    (2003)
  • J.A. Payne

    Molecular characterization of a putative K-Cl cotransporter in rat brain: a neuronal-specific isoform

    J. Biol. Chem.

    (1996)
  • S.D. Shields

    Anatomical and functional analysis of aquaporin 1, a water channel in primary afferent neurons

    Pain

    (2007)
  • K.B. Gagnon et al.

    Physiology of SLC12 transporters: lessons from inherited human genetic mutations and genetically engineered mouse knockouts

    Am. J. Physiol.

    (2013)
  • D.R. Alessi

    The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters

    Sci. Signal.

    (2014)
  • N. Markadieu et al.

    Physiology and pathophysiology of SLC12A1/2 transporters

    Pflugers Arch.

    (2014)
  • G. Gamba

    Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters

    Physiol. Rev.

    (2005)
  • K. Kaila

    Cation-chloride cotransporters in neuronal development, plasticity and disease

    Nat. Rev. Neurosci.

    (2014)
  • K.T. Kahle

    Roles of the cation-chloride cotransporters in neurological disease

    Nat. Clin. Pract. Neurol.

    (2008)
  • J.A. Payne

    Functional characterization of the neuronal-specific K-Cl cotransporter: implications for [K+]oregulation

    Am. J. Physiol.

    (1997)
  • G. Cellot et al.

    GABAergic signaling as therapeutic target for autism spectrum disorders

    Front. Pediatrics

    (2014)
  • D. Arion et al.

    Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia

    Arch. Gen. Psychiatry

    (2011)
  • J. Tornberg

    Behavioural phenotypes of hypomorphic KCC2-deficient mice

    Eur. J. Neurosci.

    (2005)
  • A. Khanna

    Limitations of current GABA agonists in neonatal seizures: towards GABA modulation via the targeting of neuronal Cl-transport

    Front. Neurol.

    (2013)
  • P. Boulenguez

    Down-regulation of the potassium-chloride cotransporter KCC2 contributes to spasticity after spinal cord injury

    Nat. Med.

    (2010)
  • V. Rangroo Thrane

    Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buffering

    Nat. Med.

    (2013)
  • J.A. Coull

    BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain

    Nature

    (2005)
  • K.T. Kahle

    Therapeutic restoration of spinal inhibition via druggable enhancement of potassium-chloride cotransporter kcc2-mediated chloride extrusion in peripheral neuropathic pain

    JAMA Neurol.

    (2014)
  • M.L. Jennings et al.

    Kinetics of activation and inactivation of swelling-stimulated K+/Cl transport. The volume-sensitive parameter is the rate constant for inactivation

    J. Gen. Physiol.

    (1990)
  • M.L. Jennings et al.

    Okadaic acid inhibition of KCl cotransport. Evidence that protein dephosphorylation is necessary for activation of transport by either cell swelling or N-ethylmaleimide

    J. Gen. Physiol.

    (1991)
  • P. de los Heros

    The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl co-transporters

    Biochem. J.

    (2014)
  • P.K. Lauf et al.

    Properties and membrane transport mechanisms of erythrocytes

  • N.C. Adragna

    Regulation of K-Cl cotransport: from function to genes

    J. Membr. Biol.

    (2004)
  • T. Boettger

    Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold

    EMBO J.

    (2003)
  • T. Boettger

    Deafness and renal tubular acidosis in mice lacking the K-Cl co-transporter Kcc4

    Nature

    (2002)
  • Cited by (93)

    View all citing articles on Scopus
    View full text